X4 PHARMACEUTICALS INC

Historical 13F Holders

Symbol
XFOR
CUSIP
98420X202
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 98420X202 since 12/18/2024, largest first.

Filer % of Class Filed
Morgan Stanley 13G/A
10.2% 3/6/2026
Event 2/28/2026
Coastlands Capital LP 13G/A
10.0% 11/13/2026
Event 9/30/2026
Empery Asset Management, LP 13G/A
10.0% 1/15/2026
Event 12/31/2025
Perceptive Advisors LLC 13G/A
8.1% 8/14/2026
Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
7.6% 11/16/2026
Event 9/30/2026
Bain Capital Life Sciences Fund, L.P. 13G/A
7.4% 2/17/2026
Event 12/31/2025
Saturn V Capital Management LP 13G
7.4% 2/17/2026
Event 10/24/2025
Deep Track Capital, LP 13G/A
6.6% 11/16/2026
Event 9/30/2026
Growth Equity Opportunities 18 VGE, LLC 13D/A
6.2% 10/29/2025
Event 10/27/2025
BlackRock, Inc. 13G 5.9% 7/30/2026
Event 6/30/2026
Trails Edge Capital Partners, LP 13G/A
5.8% 2/17/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
FMR LLC 13G/A
4.6% 10/7/2026
Event 9/30/2026
Biotechnology Value Fund L P 13G/A
3.9% 2/17/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A
2.8% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 98 105 M $304M
2026 Q2 89 95.9 M $448M
2026 Q1 82 94.2 M $389M
2025 Q4 76 85.9 M $344M
2025 Q3 41 13.7 M $46.7M
2025 Q2 51 2.15 M $4.09M
2025 Q1 2 83.0 k $20.0k